How do synthetic ETFs work? Benefits and risks
Investors who invest using the increasingly popular ETFs have probably come across the term “synthetic ETF”. But what is that anyway? • Synthetic ETF: Index replication using swap transactions• Lower…
Allianz Global Investors Outlook 2026: This is why investors could benefit from these regions
Allianz Global Investors has published its outlook for 2026. The asset manager analyzes the prospects for various stock markets worldwide.
XRP forecast: Smartest person in the world – “XRP instead of Bitcoin”
The information on this page is provided by CryptoPR. If you click on the links in the article, CryptoPR may receive a commission – at no cost to you. For…
D-Wave Quantum Stock: Post-Holiday Volatility – Insider Selling and Event Schedule in Focus
After an impressive rally in 2025, D-Wave Quantum stock is experiencing a volatile pullback in the first week of trading after Christmas. • D-Wave shares have to give up significantly…
New car: How to correctly estimate the running costs
The Germans are a driving nation. According to the Federal Motor Transport Authority, over 2.6 million vehicles were newly registered in 2021. But how do you correctly estimate the costs…
Silver shock could reignite inflation: Crypto investors bet on Bitcoin Hyper
The information on this page is provided by CryptoPR. If you click on the links in the article, CryptoPR may receive a commission – at no cost to you. For…
Growth with protection
Home » Advertorials » Growth with protection How can growth orientation be combined with increased risk sensitivity? With the actively managed…
Novo Nordisk share: With the "weight loss pill" to the year 2026 – turning point or intermediate high?
Shortly before the turn of the year, the US Food and Drug Administration (FDA) gave Novo Nordisk an important “Christmas present”: the approval of the Wegovy pill. • Wegovy pill…
Outlook 2026: Capacity issues and EMA decision are likely to determine the price of Novo Nordisk shares
Shortly before the turn of the year, the US Food and Drug Administration (FDA) gave Novo Nordisk an important “Christmas present”: the approval of the Wegovy pill.
Several Top People Leaving – What Does This Mean for the Future of Berkshire Hathaway Stock?
While Warren Buffett is increasingly withdrawing from Berkshire Hathaway, there are also some other major changes in the management of the investment company. • Warren Buffett is increasingly withdrawing from…
